These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 4108500)

  • 21. Testosterone metabolism in benign prostatic hypertrophy. Suppression by diethylstilbestrol and gestonorone capronate.
    Orestano F; Klose K; Rubin A; Knapstein P; Altwein JE
    Invest Urol; 1974 Sep; 12(2):151-6. PubMed ID: 4137236
    [No Abstract]   [Full Text] [Related]  

  • 22. Androgen metabolism in patients with benign prostatic hypertrophy.
    Voigt KD; Horst HJ; Krieg M
    Vitam Horm; 1975; 33():417-38. PubMed ID: 59462
    [No Abstract]   [Full Text] [Related]  

  • 23. Androgen dynamics in vitro in the canine prostate gland.
    Giorgi EP; Grant JK; Stewart JC; Reid J
    J Endocrinol; 1972 Nov; 55(2):421-39. PubMed ID: 4673878
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of purified plasma proteins on testosterone uptake and metabolism by normal and hyperplastic human prostate in "constant-flow organ culture".
    Mercier-Bodard C; Marchut M; Perrot M; Picard MT; Baulieu EE; Robel P
    J Clin Endocrinol Metab; 1976 Aug; 43(2):374-86. PubMed ID: 59732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen concentration in blacks with benign and malignant prostatic disease.
    Osegbe DN; Ogunlewe JO
    J Urol; 1988 Jul; 140(1):160-4. PubMed ID: 2454327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of steroids on oxytocin secretion by the human prostate in vitro.
    Assinder SJ; Nicholson HD
    Int J Androl; 2004 Feb; 27(1):12-8. PubMed ID: 14718041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes--androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens.
    Schmidt M; Weidler C; Naumann H; Anders S; Schölmerich J; Straub RH
    Arthritis Res Ther; 2005; 7(5):R938-48. PubMed ID: 16207335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular localisation of 5alpha-dihydrotestosterone in human benign prostatic hypertrophy.
    Ghanadian R; Chisholm GD; Fotherby K
    Clin Chim Acta; 1976 Dec; 73(3):521-6. PubMed ID: 63340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue.
    Baranowska B; Zgliczyński S
    Nuklearmedizin; 1979; 18(6):297-9. PubMed ID: 94161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume.
    Pejčić T; Tosti T; Tešić Ž; Milković B; Dragičević D; Kozomara M; Čekerevac M; Džamić Z
    Prostate; 2017 Jul; 77(10):1082-1092. PubMed ID: 28594074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testosterone metabolism in cultured hyperplasia of the human prostate.
    McMahon MJ; Butler AV; Thomas GH
    Acta Endocrinol (Copenh); 1974 Dec; 77(4):784-93. PubMed ID: 4139859
    [No Abstract]   [Full Text] [Related]  

  • 32. [Metabolism of 3H-testosteron and 3H-5alpha-DHT in the normal and adenomatous prostate (author's transl)].
    Becker H; Klosterhalfen H; Voigt KD
    Urol Int; 1973; 28(3):350-5. PubMed ID: 4127746
    [No Abstract]   [Full Text] [Related]  

  • 33. Altered androgen metabolism in metastatic prostate cancer.
    Kliman B; Prout GR; Maclaughlin RA; Daly JJ; Griffin PP
    J Urol; 1978 May; 119(5):623-6. PubMed ID: 77915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concentration of the endogenous antiandrogen epitestosterone and androgenic C19-steroids in hyperplastic prostatic tissue.
    Hill M; Hampl R; Petrík R; Stárka L
    Prostate; 1996 Jun; 28(6):347-51. PubMed ID: 8650070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate.
    Isaacs JT; Brendler CB; Walsh PC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):139-46. PubMed ID: 6183287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen metabolism in the epithelial and stromal components of the human hyperplastic prostate.
    Habib FK; Tesdale AL; Chisholm GD; Busuttil A
    J Endocrinol; 1981 Oct; 91(1):23-32. PubMed ID: 6170712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metabolism of sex steroid hormones in neuroendocrine organs. I. In vitro androgen metabolism in the hypophyses and epiphyses of rats during the puberal period].
    Degtiar' VG; Pavlinov SA; Loseva LA; Isachenkov VA
    Probl Endokrinol (Mosk); 1977; 23(4):70-6. PubMed ID: 20619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the metabolism of C-19 steroids in the human foeto-placental unit. 3. Dehydrogenation and reduction prducts formed by previable foetuses with androstenedione and testosterone.
    Benagiano G; Mancuso S; Mancuso FP; Wiqvist N; Diczfalusy E
    Acta Endocrinol (Copenh); 1968 Feb; 57(2):187-207. PubMed ID: 5694183
    [No Abstract]   [Full Text] [Related]  

  • 39. Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal.
    Walsh PC; Hutchins GM; Ewing LL
    J Clin Invest; 1983 Nov; 72(5):1772-7. PubMed ID: 6195192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective retention of dihydrotestosterone by prostatic nuclei.
    Anderson KM; Liao S
    Nature; 1968 Jul; 219(5151):277-9. PubMed ID: 5671431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.